scholarly article | Q13442814 |
P2093 | author name string | Arcamone F | |
P433 | issue | 12 Pt 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 5995-5999 | |
P577 | publication date | 1985-12-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Properties of antitumor anthracyclines and new developments in their application: Cain memorial award lecture | |
P478 | volume | 45 |
Q61795933 | A computational study of Anthracyclines interacting with lipid bilayers: Correlation of membrane insertion rates, orientation effects and localisation with cytotoxicity |
Q84453578 | Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide |
Q46897227 | An electron transfer approach to the preparation of highly functionalized anthraquinones |
Q39734481 | Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties |
Q42007942 | Antitumor activities of a novel 9-aminoanthracycline (SM-5887) against mouse experimental tumors and human tumor xenografts |
Q68764226 | Antitumor activity of new anthracycline analogues in combination with interferon alfa |
Q41752579 | Cardiac toxicity and antitumor activity of 4'-deoxy-4'-iodo-doxorubicinol |
Q68775552 | Comparative in vitro activity of 4'-deoxy-4'-iododoxorubicin and other anthracyclines in the human tumor clonogenic assay |
Q42390506 | Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells |
Q40488017 | Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy |
Q50892060 | Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A. |
Q60589833 | In vitro activity of 4? -iodo-4? -deoxydoxorubicin on human colo-rectal cancer as measured by a short-term antimetabolic assay |
Q73701516 | Is the drug-responsive NADH oxidase of the cancer cell plasma membrane a molecular target for adriamycin? |
Q41146888 | Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin |
Q54391054 | Lack of cross-resistance of a doxorubicin-resistant B16 melanoma line with 4'-deoxy-4'-iodo-doxorubicin |
Q70244899 | Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans |
Q39768346 | Pharmacokinetics of anticancer drugs in children |
Q34416726 | Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer |
Q67974060 | Reduced cardiotoxicity and increased cytotoxicity in a novel anthracycline analogue, 4'-amino-3'-hydroxy-doxorubicin |
Q72050216 | Response to adriamycin of transplasma membrane electron transport in adriamycin-resistant and nonresistant HL-60 cells |
Q36505025 | Synthesis and Anti-Platelet Activity of Thiosulfonate Derivatives Containing a Quinone Moiety |
Q94089192 | Synthesis of 3-Alkenyl-1-azaanthraquinones Diels-Alder and Electron Transfer Reactions |
Search more.